Three general patterns for the acquisition of antibiotic resistance have been described in microorganisms.' These bacterial modifications include: (a) the development of a mechanism for the complete, or an increased rate of, destruction of the antibiotic, (b) a decreased or complete loss of permeability of the cell for the antibiotic, and (c) the acquisition or enhancement of a mechanism for overcoming the antibiotic-inhibited process. Examples of each type of resistance have been reported from studies of microorganisms.2-'0 Only the last of the above-mentioned processes need be related to the mechanism of action of the antibiotic. One or more of these mechanisms, or a hitherto unrecognized type of alteration in cellular physiology, may be operative in the development of antibiotic resistance in a specific microorganism. In the case of erythromycin-A," one of the macrolide group of antibiotic glycosides, there has been no convincing confirmation or rejection of any of the mechanisms of resistance mentioned. Although qualitative recovery of antibiotic activity, after growth of resistant organisms in the presence of erythromycin, has been reported,12' 13 no attempt was made to demonstrate either the retention of the original chemical structure or the fate of any intracellular antibiotic. Relative to mechanism (c), Brock and Brock have described an inhibition of protein synthesis by both chloramphenicol and erythromycin in Escherichia coli.14 However, because this organism is not very sensitive to erythromycin, a very high concentration of the antibiotic (1 mg/ml) was used. No data relative to the effect of such a high antibiotic concentration on protein synthesis in a less sensitive strain of E. coli were presented.
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In order to extend the previous observations, and to confirm their validity for a microorganism sensitive to therapeutic levels of erythromycin (<1 ,.g/ml), a study was undertaken to investigate the mechanism of action of erythromycin and to explore the biochemical basis of resistance to erythromycin in Bacillus subtilis.
Results with an erythromycin-resistant, genetically stable mutant were compared with those obtained with the erythromycin-sensitive parent strain. The data obtained demonstrate that neither degradation of the antibiotic nor change in permeability to the antibiotic play significant roles in resistance. Erythromycin appears to interfere with some aspect of the utilization of amino acids by the sensitive strain of B. subtilis. This same process is not significantly inhibited, at comparable antibiotic levels, in the erythromycin-resistant strain.
Experimental. vestigation have the designations, genetic properties, and erythromycin sensitivities shown in Table 1 .
Stock cultures of B. subtilis were maintained as described previously.18 Bacteria were first grown in minimal salts medium16 containing glucose (0.5%), neutralized acid hydrolyzed casein (0.02%), L-tryptophan (50 ,ug/ml), and adenine hydrochloride (50 Mg/ml). All experiments were carried out at 370C with logarithmically growing cells in the above medium on a New Brunswick rotary shaker, either model WBR at 200 rpm, 1/2' stroke, or Model G-25 at 300 rpm, 1" stroke.
Turbidities were determined on a Klett-Summerson Colorimeter (filter number 54) and correlated with viable cell count (one Klett unit is approximately equivalent to 3 X 106 bacteria/ml).
Preparation of H3-erythromycin: Erythromycin-A was synthesized by Streptomyces erythreus, utilizing sodium 2,3-H3-propionate (Volk Radiochemicals, Inc.) as a precursor. Preliminary isolation of the erythromycin synthesized was as described." The final purification was by partition chromatography at 250C on a powdered cellulose column (34 X 1.8 cm, 50 g) employing the lower layer of a methylcyclohexane: n-butanol: acetone: phosphate buffer (pH 6.85, 0.01 M) system (75:15:10:25 v/v) as the stationary phase (2:1 w/v) and the upper layer of the same system as the mobile phase. The effluent fractions containing the bulk of the antibiotic activity and radioactivity were found to correspond exactly. Solute isolated from these fractions gave only a single radioactive spot (corresponding to authentic erythromycin-A) on paper chromatography, using the above solvent system and also using a modification of that system.20 Both of these systems have been shown capable of separating erythromycin-A from closely related compounds, some of which have antibiotic activity. Radioactive purity of the H3-erythromycin was further indicated by retention of the activity on dilution with nonradioactive erythromycin, followed by chemical derivatization and purification as erythromycin-2'-O-benzoate.'9 The specific activity of the H3-erythromycin obtained from this preparation was 2 X 104 cpm per ug.
Recovery of H3-erythromycin from cultures of B. subtilis: Experiments were carried out in which B. subtilis was grown with H3-erythromycin (20,000 cpm/ug) added to the standard minimal salts medium. After the desired level of growth was attained, each incubation was terminated by cooling to 0°C. In the experiments from which both extra-and intracellular erythromycin were recovered, a large amount of nonradioactive erythromycin (25 mg) was added, after which the bacteria were lysed with lysozyme and the erythromycin fraction was isolated by chloroform extraction at pH 9.5. 19 In the experiment from which only intracellular erythromycin was recovered, the bacteria (approximately 7.5 X 1016 organisms) were first washed (five times, 10 ml each time) with minimal salts medium containing glucose (0.5%) and nonradioactive erythromycin (10 ug/ml). Finally, a large amount of nonradioactive erythromycin (25 mg) was added, after which the bacteria were lysed with lysozyme and the antibiotic was recovered by diethyl ether extraction at neutral pH. In both cases, recovery of H3-erythromycin was calculated by the isotope dilution method, after the preparation, isolation, and purification of erythromycin-2"-Obenzoate. '9 Studies of H3-erythromycin uptake by B. subtilis: The uptake of H3-erythromycin from the extracellular medium, by erythromycin-sensitive and erythromycin-resistant bacteria, was determined by filtering an aliquot of the bacterial suspension through a membrane filter (Millipore, Type HA, 25 mm). The bacteria collected in this manner (about 5 X 108 organisms) were then quickly washed by repeated suspension in the filtration apparatus (seven times, 2.5 ml each time) in minimal salts medium containing glucose (0.5%) and nonradioactive erythromycin (10 jMg/ml). After washing, the bacteria and the membrane filter were dried by gentle heating (<400C) and then added to a liquid scintillation counting vial containing 10 ml of the toluene-based scintillant described by Davidson.21 The toluene, besides lysing the bacteria, permeates the pores of the membrane filter and renders it almost completely transparent.
VOL. 50, 1963 BIOCHEMISTRY: TA UBMAN, YOUNG, AND CORCORAN 957
Lysozyme-spheroplasts (osmotically sensitive), prepared according to the method of Landman,22 were used to determine the role of the intact cell wall of B. subtilis in erythromycin uptake. After collection by gentle filtration, the spheroplasts were washed (as described above) with a solution containing sodium succinate (0.5 M), MgSO4 (0.01 M), and EDTA (0.005 M).
Studies of H3-tryptophan and C'4-adenine uptake by B. subtilis: The experimental techniques used were essentially the same as outlined above for the studies of HI-erythromycin uptake, except that the nonradioactive forms of the compounds being studied were added to the resuspending solution. The C14-adenine hydrochloride (0.02 1C/mg) and the H'-tryptophan (4.0 AC/mg) were obtained from Calbiochem and Volk Radiochemicals, Inc., respectively.
Results and Discussion.-The initial experiments with the erythromycin-resistant strain of B. subtilis showed that 90 per cent of the erythromycin which was added to cultures of the bacteria could be recovered after growth ( Table 2 , flask 1).
From 94-97 per cent of added erythromycin was recovered from two control experiments, one of which employed the erythromycin-sensitive strain of B. subtilis (Table 2 , flask 2) and the other of which received no bacterial inoculum ( Table 2 , flask 3). In these experiments the antibiotic was recovered from the combined medium and the lysozyme-lysed bacteria. In a different experiment the resistant bacteria, after growth in the presence of tritiated erythromycin, were washed repeatedly to remove adsorbed H3-erythromycin and then lysed with lysozyme. Here it was possible to recover 100 per cent of the radioactivity taken up by the bacteria.
In this case the external erythromycin concentration was 0.5 jig per ml (2 X 104 cpm/,ug) and the uptake of erythromycin was 0.035 ,ug per 1011 bacteria. Collectively, these experiments rule out the possibility that antibiotic degradation plays a significant role in the mechanism by which the erythromycin-resistant mutant strain of B. subtilis grows in the presence of normally bacteriostatic concentrations of erythromycin. The results are in agreement with the qualitative findings of both Haight and Finland'2 and Straightoff,'3 who investigated this same problem by means of a procedure similar to that developed by Gots23 to detect penicillinase activity. Since loss of extracellular biological activity served as the sole criterion of antibiotic destruction in these studies, subtle chemical change would not have been recognized unless it led to marked diminuition of antibiotic activity. Furthermore, these experiments, as well as those reported in Table 2 , did not test the possibility that the mutant, resistant bacteria have acquired some mechanism for the intracellular destruction of erythromycin prior to its reaching the normal site of antibacterial action. The fact that gross intracellular destruction of erythromycin does not occur is demonstrated by the result of the experiment in which the erythromycin taken up by the resistant bacteria was quantitatively recovered.
The recovery of unchanged erythromycin from the resistant, mutant forms of B. subtilis does not rule out a change in permeability of the bacterial cell for the antibiotic as being an essential part of the resistance mechanism. Accordingly, several experiments were carried out to investigate the possible role of antibiotic exclusion in the resistance to erythromycin observed in B. subtilis. Although a difference in uptake of HI-erythromycin, between the sensitive and resistant bacteria, was consistently observed in these experiments (Figs. 1 and 2) it was much lower than the 100-fold difference in their sensitivity (Table 1) . A similar difference in the uptake of antibiotic also was noted in lysozyme-spheroplasts of the sensitive and resistant strains. The data presented graphically in Figure 1 indicate that there is an initial rapid uptake of the antibiotic and then a slower release until an equilibrium level is attained. The amount of antibiotic actually taken up from the extracellular medium is insignificant in terms of lowering the concentration of antibiotic present. We can offer no logical explanation for the complex uptake phenomenon represented in Figure 1 . With increasing extracellular concentrations of the antibiotic, the uptake of H3-erythromycin appears to increase proportionately in both the sensitive and resistant strains of B. subtilis (Fig. 2) . This occurs in spite of the fact that cell multiplication ceases in the erythromycin-sensitive strain when an antibiotic level of 7.5 ,.g per 1011 bacteria is reached. Using the data presented in Figure 2 , and the approximate size of the bacteria, one can calculate24 both the internal concentration of the antibiotic (assuming homogeneous dispersion) and the degree of its concentration or dilution as compared with that in the extracellular fluid. The erythromycin-sensitive strain can effect an antibiotic concentration of about 60-fold, while the resistant organism concentrates the drug only 20 times above the extracellular level. At the higher antibiotic concentrations, as represented in Figure 2 , the uptake of erythromycin per bacterium for the resistant strain has already surpassed the level which inhibits multiplication in the sensitive strain (.7.5 ug erythromycin/101" bacteria). In spite of this there is no effect on the multiplication rate of the resistant bacteria. This provides a further indication that a loss of permeability cannot explain the observed resistance. It jug ERYTHROMYCIN /ml. OF MEDIUMtion of the antibiotic. If so, this, coupled with the difference in uptake which is observed ( Fig. 1) , might result in a substantial difference in the amount of erythromycin which reaches the sensitive site within the bacterium. Results to be presented below minimize this possibility by showing that some other mechanism for the resistance does in fact exist. In the case of B. subtilis there is a rapid exchange between intra-and extracellular erythromycin. The data showing this, in the case of the sensitive strain, are plotted in Figure 3 . Similar results were obtained using the erythromycin-resistant strain, although the accuracy was below that obtained with the sensitive strain because a smaller amount of antibiotic was taken up. The almost complete recovery of intact erythromycin from the combined medium and bacteria of B. subtilis cultures (Table 2) is particularly significant in view of this rapid and reversible uptake of the antibiotic by the bacterial cells. It seems likely that much of the H3-erythromycin reisolated from the medium in these experiments had been "taken up" by the bacteria, only to be released again unchanged. If intracellular destruction could occur, then the extracellular erythromycin should have been gradually diluted with the degradation products, if these could be released by the bacteria. If they could not be released, the extracellular pool of erythromycin should have decreased in size. Since neither of these effects was noted, the recovery of erythromycin from the medium in these experiments is significant in supporting the conclusion that erythromycin is not destroyed intracellularly by the resistant bacteria.
An approximation of the over-all processes of protein and nucleic acid synthesis in the erythromycin-resistant and -sensitive strains of B. subtilis was possible because of the requirements of these organisms for exogenous L-tryptophan and adenine. Studies of the utilization of these two substrates were carried out in both the presence and the absence of erythromycin (1 ,Ag/ml). With erythromycin present, the resistant mutant grows at an essentially unaltered rate, while growth of the sensitive strain is reduced to about 20 per cent of the normal rate (as measured turbidimetrically). The data obtained from these studies are presented in Figures 4A-D. They were obtained by measuring both the turbidity and bacterial radio- incorporation system derived from yeast and E. coli, have recently studied some of the characteristics of chloramphenicol action. In collaboration with these authors, and using a similar cell-free system derived from the above strains of B. subtilis, we
have been able to demonstrate that the incorporation of amino acids (lysine, valine, leucine), by extracts from the sensitive cells is markedly inhibited by erythromycin, while the incorporation is only slightly inhibited in extracts from the resistant cells. 26 The results obtained with the cell-free system, besides demonstrating the existence of a method for further study of the mechanism of erythromycin action, increase the probability that resistance to the antibiotic in B. subtilis is related to the effect of erythromycin on amino acid utilization. The possibility that resistance results from a difference in intracellular distribution of the erythromycin (see above) between the resistant and sensitive forms of the B. subtilis seems unlikely, since a difference in sensitivity to the antibiotic is maintained in the cell-free state.
The findings presented in this communication provide strong evidence that the mechanism of resistance of a B. subtilis mutant to erythromycin is one whereby an increased tolerance to the antibiotic-inhibited process has developed. The (1 /Ag/ml).
erythromycin seems to interfere with some aspect of amino acid utilization in sensitive bacteria.
Summary.-Erythromycin resistance has been studied in a resistant, genetically stable strain of B. subtilis and compared with the erythromycin-sensitive parent strain. Destruction of the antibiotic has been ruled out as a significant factor in this resistance, and exclusion of the antibiotic also does not appear to account for the change in erythromycin sensitivity. Using the auxotrophic requirements (Ltryptophan and adenine), it has been demonstrated that the utilization of amino acids is inhibited by erythromycin in the sensitive bacteria and that the resistant cells are able to overcome this inhibition. Thus, the mechanism of resistance seems to be one in which an increased tolerance to the antibiotic-inhibited process has occurred. 
